Inventor
LEE SUNG-HYUNG
US20 patents
⚠️ This page may combine multiple inventors who share the name “LEE SUNG-HYUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENCOR INC
18 patentsUS9856327B2Jan 2, 2018
Heterodimeric antibodies to CD3 X CD123
XENCOR INC72 citations98
US11225528B2Jan 18, 2022
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC11 citations94
US10428155B2Oct 1, 2019
Trispecific antibodies
XENCOR INC39 citations94
US10259887B2Apr 16, 2019
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC25 citations94
US9850320B2Dec 26, 2017
Heterodimeric antibodies to CD3 X CD20
XENCOR INC13 citations92
US11225521B2Jan 18, 2022
Heterodimeric antibodies that bind somatostatin receptor 2
XENCOR INC11 citations85
US11472890B2Oct 18, 2022
Heterodimeric antibodies that bind ENPP3 and CD3
XENCOR INC9 citations84
US10316088B2Jun 11, 2019
Heterodimeric antibodies that bind somatostatin receptor 2
XENCOR INC11 citations84
US11945880B2Apr 2, 2024
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US11859011B2Jan 2, 2024
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US10913803B2Feb 9, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US10889653B2Jan 12, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC2 citations73
US12359002B2Jul 15, 2025
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US12054545B2Aug 6, 2024
Heterodimeric antibodies that bind somatostatin receptor 2
XENCOR INC0 citations62
US11673972B2Jun 13, 2023
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US11111315B2Sep 7, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US12398207B2Aug 26, 2025
Heterodimeric antibodies that bind CD3 and CLDN6
XENCOR INC1 citations61
US11739144B2Aug 29, 2023
Heterodimeric antibodies that bind CD3 and CLDN6
XENCOR INC0 citations59